Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Little sedi action.

<< Previous

Bullboard Posts

Next >>

Comment by westcoast1000on Feb 27, 2023 8:20pm

129 Views

Post# 35308489

RE:RE:RE:RE:RE:RE:RE:RE:RE:Little sedi action.

Eileen,

Thanks for your reply but it gives me pause. You say there has been "some speculation that we could "sell" panc and Mbc for mid single digits blns". Could you point to where this speculation has occurred?

I have been in ONCY for well over 10 years and read everything, compulsively about this stock. I was on the previous Yahoo boards back to deep into the V2 time and then the current version. I have never seen this speculation. I posted extensively on the V2 board and subsequently here.

So could you please indicate where this speculation was posted or where it was discussed. Thanks.

<< Previous

Bullboard Posts

Next >>

Three micro-cap value stocks trading at peak pessimism